Red Nucleus Neurons In Progressive Supranuclear Palsy is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The red nucleus (nucleus ruber) is affected in Progressive Supranuclear Palsy (PSP), contributing to the motor and oculomotor deficits seen in this tauopathy. Located in the midbrain, the red nucleus integrates cerebellar and cortical inputs to coordinate movement.
¶ Location and Structure
- Position: Midbrain tegmentum, between the substantia nigra and the trochlear nucleus
- Subdivisions:
- Parvocellular (small-celled) part: Receives cerebellar input
- Magnocellular (large-celled) part: Origin of rubrospinal tract
- Size: Approximately 5-6 mm in diameter
- Blood supply: Basilar and posterior cerebral arteries
- Inputs: Cerebellar nuclei (via superior cerebellar peduncle), motor cortex (via corticorubral fibers)
- Outputs: Rubrospinal tract, rubromotor nuclei connections, thalamic projections
- Magnocellular neurons: Large cholinergic neurons projecting to spinal cord
- Parvocellular neurons: Smaller GABAergic interneurons
- Projection neurons: Send axons to contralateral spinal cord
- Neuronal loss: Moderate loss of red nucleus neurons
- Neurofibrillary tangles: 4R-tau positive inclusions
- Gliosis: Reactive astrocytic changes
- Pigment loss: Neuromelanin depletion
- 4R-tau predominance: Characteristic of PSP
- Tau inclusions: Globose neurofibrillary tangles
- Neuronal vulnerability: Selective susceptibility of large neurons
- Spread pattern: Related to disease progression
- Rubral tremor: Resting and intention tremor
- Limb ataxia: Cerebellar-like incoordination
- Weakness: Mild to moderate weakness
- Spasticity: Increased tone
- Vertical gaze palsy: Supranuclear vertical gaze impairment
- Slow saccades: Reduced saccadic velocity
- Convergence insufficiency: Difficulty with near vision
- Blepharospasm: Eyelid closure spasms
- Hyperphosphorylation: Abnormal tau phosphorylation
- Aggregation: Formation of insoluble filaments
- Axonal transport disruption: Impaired microtubule function
- Synaptic dysfunction: Pre-synaptic tau pathology
- Glutamate excess: Dysregulated excitatory neurotransmission
- Calcium dyshomeostasis: Pathological calcium influx
- Metabolic compromise: Energy failure
- Microglial activation: Chronic inflammation
- Cytokine production: Pro-inflammatory mediators
- Oxidative stress: ROS and RNS formation
- Lewy body pathology
- Less prominent red nucleus involvement
- Different pattern of degeneration
- Asymmetric onset
- Variable red nucleus pathology
- 4R-tau pathology similar to PSP
- Physical therapy: For gait and balance
- Occupational therapy: Daily living adaptations
- Speech therapy: For dysarthria
- Tau-targeted therapies: Aggregation inhibitors
- Immunotherapy: Anti-tau antibodies
- Neuroprotection: Neurotrophic factors
The study of Red Nucleus Neurons In Progressive Supranuclear Palsy has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
-
Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy. Neurology. 1996;47(1):1-9. PMID: 8710059.
-
Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. Arch Neurol. 1964;10:333-359. PMID: 14120784.
-
Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA. Neuropathology of progressive supranuclear palsy. Acta Neuropathol. 2010;120(1):43-58. PMID: 20437155.
-
Liao YC, Hsu YT, Wu YR. Red nucleus involvement in movement disorders. J Neurol Sci. 2020;411:116709. PMID: 32087432.
-
Ramos VF, Eslinger PJ. The red nucleus: from motor control to cognition. Brain Struct Funct. 2022;227(7):2237-2252. PMID: 35554567.
-
van Domburg PH, ten Donkelaar HJ. The human red nucleus and rubospinal tract. Adv Anat Embryol Cell Biol. 1999;146:III-79. PMID: 10319131.
-
Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009;8(3):270-279. PMID: 19233041.
-
McFarland NR. Progressive supranuclear palsy: an update. Curr Neurol Neurosci Rep. 2018;18(7):41. PMID: 29767333.